Skip to main navigation
Molecular Partners

> Top Menu

  • Partnering
  • Careers
  • Patients
  • Contact Us

> Investor Relations

  • Home
  • About Us
    • Purpose
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • DARPin Science
    • Our DARPin Therapeutics
    • Radio-DARPins
    • Switch-DARPins
    • Scientific Publications & Presentations
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
      • General Meeting
    • Scientific Documents
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • SEC Filings
      • Financial Reports
    • IR Resources
      • Email Alerts
      • Contact IR
  • Partnering
  • Careers
  • Contact Us

> Top Menu

  • Partnering
  • Careers
  • Patients
  • Contact Us

> Investor Relations

  • Home
  • About Us
    • « Back
    • Purpose
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • DARPin Science
    • « Back
    • Our DARPin Therapeutics
    • Radio-DARPins
    • Switch-DARPins
    • Scientific Publications & Presentations
  • Pipeline
  • Investors
    • « Back
    • Overview
    • News & Events
      • « Back
      • News Releases
      • Events
      • Presentations
      • General Meeting
    • Scientific Documents
    • Stock Information
      • « Back
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • « Back
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • « Back
      • SEC Filings
      • Financial Reports
    • IR Resources
      • « Back
      • Email Alerts
      • Contact IR
  • Partnering
  • Careers
  • Contact Us

Investors

Investors

SHARE PRICE

> View All Stock

  • Detailed Share Information
Latest News
Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors
Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes
Molecular Partners to Hold Three Poster Presentations at AACR 2026

> View All News

  • All News
Upcoming Events
April 14, 2026
Annual General Meeting
May 12, 2026
Interim Management Statement Q1 2026
August 25, 2026
Half Year Results 2026 (unaudited)

> View All Events

  • All Events
Latest Presentation
March 12, 2026
Corporate Presentation – Full Year 2025 Financials
February 2, 2026
MP0712: First patient imaging and dosimetry data presented at TWC 2026, Clinical Outlook
January 15, 2026
44th Annual JPMorgan Healthcare Conference Presentation

> View All Presentations

  • All Presentations
Latest Financial Documents
March 12, 2026
Annual Report FY2025
October 30, 2025
Q3 Financial Statement 2025
August 25, 2025
H1 2025 Business Update and Financial Statements

> View All Reports

  • All Annual Report
Seth Lewis

Seth Lewis,
EVP Corporate Finance

Contact Seth

STAY INFORMED

Subscribe to email alerts of your choosing

SUBSCRIBE

Institutional investors:

  REQUEST 1-1 / CALL

powered by schedulR

> Footer Menu

  • Cookie Notice
  • Privacy & Disclaimer
  • Contact Us

> Footer Social

© 2026 Molecular Partners.